Eurosurveillance remains in the updated list of the Directory of Open Access Journals (DOAJ). It was first added to the DOAJ on 9 September 2004. Eurosurveillance is also listed in the Securing a Hybrid Environment for Research Preservation and Access / Rights MEtadata for Open archiving (SHERPA/RoMEO) [2], a database which uses a colour‐coding scheme to classify publishers according to their self‐archiving policy and to show the copyright and open access self-archiving policies of academic journals. Eurosurveillance is listed there as a ‘green’ journal, which means that authors can archive pre-print (i.e. pre-refereeing), post-print (i.e. final draft post-refereeing) and archive the publisher's version/PDF.

The Agriculture, Fisheries and Conservation Department (AFCD,
http://www.afcd.gov.hk/) of the government of Hong Kong
recently reported outbreaks of avian influenza in two chicken farms in Hong Kong (1), as well as sporadic infections in
wild fowl found dead in Hong Kong (2). As a result, control measures have been implemented. These included the slaughter of
around 16 000 chickens, closure and disinfection of one of the live poultry markets which had contact with the farms and
the halting of imports of chickens from mainland China (3). The virus has been partially typed and found to be influenza A
(H5). The virus is not the same strain of influenza A (H5N1) (4) that crossed over to humans in 1997, causing six
fatalities (5). Outbreaks of avian influenza due to influenza A (H5N1) viruses occurred in poultry in Hong Kong in May 2001
and February 2002, resulting in culls of about one million chickens on each occasion. Neither of these outbreaks was
associated with transmission to humans. The last reported incident of transmission of avian influenza (H9N2) to humans was
in 1999 in two young children in Hong Kong and the resulting illness was reported to be mild and self limited (6).

After the poultry outbreaks in February 2002, the Hong Kong authorities initiated a pilot vaccination programme in 21
chicken farms in one area of the territory. In light of the recent outbreak, a decision has been taken to expand the
vaccination programme to more farms in the vicinity (7). Strict licensing conditions are also enforced at chicken farms
(there are 157 chicken farms in Hong Kong) by the AFCD. These include prohibiting sales direct to retail outlets and
improving sanitary conditions with disinfection facilities (8). The AFCD also conducts routine random virological testing
of chickens and monitors health conditions of chickens closely.

The demand for freshly slaughtered poultry in Hong Kong outstrips supply and so there is the continued importation of
chickens from mainland China, where poultry farming is not so strictly licensed and regulated. This means that the risk of
outbreaks of avian influenza in Hong Kong is likely to remain. The major concern is the possibility of a recombination of
an avian influenza virus with another human or animal influenza virus creating a virus which is more adapted for human to
human transmission, or a mutation of the existing avian viruses which makes them more transmissible to humans. Genetic
analysis of the strains from the outbreaks in May 2001 and February 2002 has shown that they differed from those that
caused the human fatalities in 1997 (9). It has been suggested that the close relationship between the human populations in
southern China (including Hong Kong) and domestic animal populations such as poultry and pigs, and wild fowl, contributes
to an increased risk of the emergence of novel influenza viruses in this area (10). The high standards maintained by the
Hong Kong authorities in surveillance and control of avian influenza is therefore an essential part of the enhanced
surveillance, which has been implemented in the region and for the global surveillance for future pandemic threats (11).

Disclaimer: The opinions expressed by authors contributing to Eurosurveillance do not necessarily reflect the opinions of the European Centre for Disease Prevention and Control (ECDC) or the editorial team or the institutions with which the authors are affiliated. Neither ECDC nor any person acting on behalf of ECDC is responsible for the use that might be made of the information in this journal. The information provided on the Eurosurveillance site is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. Our website does not host any form of commercial advertisement. Except where otherwise stated, all manuscripts published after 1 January 2016 will be published under the Creative Commons Attribution (CC BY) licence. You are free to share and adapt the material, but you must give appropriate credit, provide a link to the licence, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.